Covered Call Analyzer AGGRESSIVE "STOCKS-TO-CONSIDER"
for April, 2003
|
Company Name |
Stock Symbol |
Stock Price |
# of shares |
Total Cost* |
Option Symbol |
May Option Price |
Income from sale* |
Strike Price |
Projected return if Called after one month* |
Actual $ return* |
Actual % Return* |
Amlin Pharm. | AMLN | $16.12 | 400 | $9,692 | UMQEE | $0.65 | $370 | 25 | 57% | +$4,430 | +46% |
| Comments: |
Not called. Sold Jun20 at 1.20. Not called. All positions sold at $21.72 to close out position. |
||||||||||
| IGEN Intl. | IGEN | $34.07 | 200 | $6,834 | GQEU | $2.00 | $380 | 37.5 | 15% | +$546 | +8% |
| Comments: |
Not called. Sold Jun37.5 at 2.25. Not called. Sold all shares at $32.75 to close out position. |
||||||||||
| ISS Group | ISSX | $11.73 | 800 | $9,404 | ISUEV | $0.75 | $580 | 12.5 | 12% | +$1,176 | +12% |
| Comments: |
Called. |
||||||||||
| Delta Airlines | DAL | $11.65 | 800 | $9,340 | DALEV | $0.60 | $460 | 12.5 | 12% | +$1,120 | +12% |
| Comments: |
Called. |
||||||||||
| Genesis Micorchip | GNSS | $13.92 | 700 | $9,764 | QFEEC | $0.60 | $400 | 15 | 11% | +$1,136 | +11% |
| Comments: |
Called. |
||||||||||
| IGEN Intl. | IGEN | $34.07 | 200 | $6,834 | GQEG | $2.95 | $570 | 35 | 10% | +$736 | +10% |
| Comments: |
Called. |
||||||||||
| Broadcom, Inc. | BRCM | $16.52 | 600 | $9,932 | RCQEW | $0.75 | $430 | 17.5 | 10% | +$998 | +10% |
| Comments: |
Called. |
||||||||||
| Noven Pharm. | NOVN | $14.05 | 700 | $9,855 | NPQEC | $0.50 | $330 | 15 | 10% | ($1,272) | -13% |
| Comments: |
Exercised get-out price at $11.94 after buying back calls at 0.15. |
||||||||||
| Fairchild Semi. | FCS | $11.88 | 800 | $9,524 | FCSEV | $0.50 | $380 | 12.5 | 9% | +$856 | +9% |
| Comments: |
Called. |
||||||||||
| ICOS Corp. | ICOS | $22.00 | 400 | $8,820 | IIQEX | $1.25 | $480 | 22.5 | 6% | +$660 | +6% |
| Comments: |
Called. |
||||||||||
|
All positions closed out with portfolio value up +$10,387. |
|||||||||||
The stocks listed above are for illustrative and educational purposes only and should not be construed as an endorsement, recommendation, or solicitation to buy or sell any particular security.